Clinical trial
Predictive Model for High-Flow Nasal Cannula Failure Based on Metabolomics and Clinical Data: COVID-19 As a Use Case
NCT06695442 is registered in ClinicalTrials.gov with Hospital del Mar Research Institute (IMIM) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Model for High-Flow Nasal Cannula Failure Based on Metabolomics and Clinical Data: COVID-19 As a Use Case
- Lead sponsor
- Hospital del Mar Research Institute (IMIM)
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2020
- Completion date
- December 1, 2021
- Enrollment
- 111 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute hypoxemic respiratory failure, covid 19